Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:3166-3174, 2006
DOI: 10.2337/db06-0271
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vionnet, N.
Right arrow Articles by Lathrop, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vionnet, N.
Right arrow Articles by Lathrop, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations

Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene

Nathalie Vionnet1, David Tregouët1, Gbenga Kazeem2, Ivo Gut3, Per-Henrik Groop4,5, Lise Tarnow6, Hans-Henrik Parving6, Samy Hadjadj7, Carol Forsblom4,5, Martin Farrall2, Dominique Gauguier2, Roger Cox8, Fumihiko Matsuda3, Simon Heath3, Alexandre Thévard1, Rachel Rousseau1, François Cambien1, Michel Marre9,10, and Mark Lathrop3

1 L’Institut National de la Santé et de la Recherche Médicale (INSERM), U525, Université Pierre et Marie Curie-Paris6, Paris, France
2 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K
3 Centre National de Génotypage, Evry, France
4 Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
5 Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland
6 Steno Diabetes Centre, Copenhagen, Denmark
7 Endocrinology-Diabetology Department, INSERM ERM 324, Poitiers Hospital, Poitiers, France
8 Mammalian Research Council, Oxford, U.K
9 Department of Diabetology, Bichat Hospital, Paris, France
10 INSERM U695, Xavier Bichat University of Medicine, Paris, France

Address correspondence and reprint requests to Nathalie Vionnet, INSERM U525, Centre National de Génotypage, 2, Rue Gaston Crémieux, 91006 Evry Cedex, France. E-mail: vionnet{at}cng.fr

Abbreviations: LD, linkage disequilibrium; SNP, single nucleotide polymorphism; TDT, transmission disequilibrium test

Linkage studies have mapped loci for diabetic nephropathy and associated phenotypes on chromosome 3q. We studied 14 plausible candidate genes in the linkage region because of their potential role in vascular complications. In a large-scale study of patients from Denmark, Finland, and France who have type 1 diabetes, 1,057 case and 1,127 control subjects, as well as 532 trios, were investigated for association with diabetic nephropathy. We analyzed 69 haplotype-tagging single nucleotide polymorphisms and nonsynonymous variants that were identified by sequencing. Polymorphisms in three genes, glucose transporter 2 (SLC2A2), kininogen (KNG1), and adiponectin (ADIPOQ), showed nominal association with diabetic nephropathy in single-point analysis. The T-allele of SLC2A2_16459CT was associated with a decreased risk of diabetic nephropathy (odds ratio 0.79 [95% CI 0.66–0.96], P = 0.016), whereas the T-allele of KNG_7965CT and the A-allele of ADIPOQ_prom2GA were associated with increased risk of nephropathy (1.17 [1.03–1.32], P = 0.016; 1.46 [1.11–1.93], P = 0.006, respectively). Analyses of the transmission disequilibrium test showed similar trends only for ADIPOQ_prom2GA with the overtransmission of the A-allele to patients with diabetic nephropathy (1.52 [0.86–2.66], P = NS) and of the G-allele to patients without diabetic nephropathy (0.50 [0.27–0.92], P = 0.026). The overall significance for this variant (nominal P = 0.011) suggests that ADIPOQ might be involved in the development of diabetic nephropathy.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden
Genetic Factors in Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. J. Williams, G. Qiu, H. K. Usui, S. R. Dunn, P. McCue, E. Bottinger, R. V. Iozzo, and K. Sharma
Decorin Deficiency Enhances Progressive Nephropathy in Diabetic Mice
Am. J. Pathol., November 1, 2007; 171(5): 1441 - 1450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.